| Betterchem |
|
|
| FDA approval activities
for this prescription drug:
Ethosuximide Capsules, 250 mg, Banner Pharmacaps ANDA 40-430 10/28/02 Ethosuximide Syrup,250 mg/5 mL, Pharmaceutical Associates, ANDA 40-253 Zarontin (ethosuximide) Capsules, Pfizer NDA 12-380/S29 4/19/02 5/2/02 Zarontin (ethosuximide) 250 mg Capsules and 250 mg/5 ml Syrup. Parket-Davis NDA 12380/S-22/23/25 ETHOSUXIMIDE Capsule; 250MG ETHOSUXIMIDE BANNER PHARMACAPS 012380 ETHOSUXIMIDE Capsule; 250MG ZARONTIN PARKE DAVIS 081306 ETHOSUXIMIDE Syrup; 250MG/5ML ETHOSUXIMIDE COPLEY 080258 ETHOSUXIMIDE Syrup; 250MG/5ML ZARONTIN PARKE DAVIS 040253 ETHOSUXIMIDE Syrup; 250MG/5ML ETHOSUXIMIDE ASSOC |
© 2007 Betterchem Corp.
|